Similar Items: Predictive factors of response to anti-CGRP pathway drugs in people with multiple sclerosis
- Pharmacological mechanisms underlying neurovascular alterations related to resistant and refractory migraine: CGRP pathways and beyond
- CGRP-targeted migraine treatment and early pathophysiology in experimental subarachnoid hemorrhage
- CGRP-provoked headache is associated with a neuroimmune signature in idiopathic intracranial hypertension
- Sex-dependent central amygdala physiology after supradural CGRP exposure is associated with migraine-like behaviors
- Real-world effectiveness and safety of CGRP monoclonal antibodies in elderly migraine patients: a Korean multicenter study
- Abnormal Brain Structure and Function in People with Shoulder Pain: A Systematic Review of Neuroimaging Studies